Specializations
Lazy Eye (Amblyopia)
Glaucoma (Eye Pressure)
Yellow Spot Disease
Diabetic Retinopathy
Mostrar más
Birth place and date
Konya, 1984
Foreign Languages Known
English, German
Educational Status and Experience
Kayseri City Hospital, Kayseri, Associate Professor (2023)
St. Franziskus-Hospital, Zentrum für Refraktive Chirurgie
Germany, Cornea and Refractive Surgery Fellowship (2022-2023)
Kayseri City Hospital, Kayseri, Specialist Doctor (2018-2022)
Hatice-Muammer Kocatürk State Hospital, Kayseri, Specialist Doctor (2017-2018)
Gazi Yaşargil Training and Research Hospital, Diyarbakır, Specialist Doctor (2014-2017)
Bülent Ecevit University Faculty of Medicine, Zonguldak, Specialization in Medicine (2010-2014)
Abant İzzet Baysal University Faculty of Medicine, Bolu, Medical Education (2007-2010)
GATA Gülhane Military Medical Faculty, Ankara, Medical Education (2003-2007)
Kuleli Military High School, Istanbul (1999-2003)
Case Experience
Experience of over 10,000 surgical cases.
Associations of which he is a member
ESOPRS (European Society Of Ophthalmic Plastic And Reconstructive Surgery), Member, 2022
ESCRS (European Society of Cataract and Refractive Surgeons), Member, 2021
MRCSEd (The Royal College of Surgeons of Edinburgh), Member, 2021
TOD-GO (Turkish Ophthalmology Association - Young Ophthalmologists Group), Member, 2018
TOD (Turkish Ophthalmology Association), Member, 2010
Certificates
2016 European Board of Ophthalmology Diploma, FEBO, Paris
2019 International Council of Ophthalmology (ICO), Visual Sciences
2020 International Council of Ophthalmology (ICO), Optics and Refraction
2020 International Council of Ophthalmology (ICO), Clinical Science
2021 International Council of Ophthalmology (ICO), Advanced Examination, FICO
2019 Ophthalmology Clinical Research Training, Istanbul
2014 Communication, Anterior Segment and Toric Lens Applications, Prague
Books
Sea Sword
MCQ for International Ophthalmology Board Exams – 2
Chapter 4, Oculoplasty, (2021). Anatolian Bookstore.
Awards
FICO, International Fellowship Scholarship 2022
TÜBİTAK, International Scientific Publications Incentive Scholarship UBYT, 2022
TÜBİTAK, International Scientific Publications Incentive Scholarship UBYT, 2020
Ministry of Health, Certificate of Appreciation, 2018
Mostrar másCV
Place and Date of Birth
Kayseri, 1989
Foreign Languages
English, German
Education and Experience
Istanbul University Faculty of Medicine 2006-2012
Beyoğlu Eye Hospital 2012-2017
Associations of which he is a member
Turkish Medical Association
Turkish Ophthalmology Association
Books
1. Presbyopia Corrective Intraocular Lenses
2. Cataract and Its Treatment
Congress and Symposium Participation
TURKISH OPHTHALMOLOGY ASSOCIATION 47TH NATIONAL CONGRESS
06-10 NOVEMBER 2013
TURKISH OPHTHALMOLOGY ASSOCIATION CATARACT AND RECRACTION SURGERY UNIT VII. LIVE SURGERY SYMPOSIUM
22-23 FEBRUARY 2014
CERTIFICAE OF ATTENDANCE EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS
13-17 SEMPTEMBER 2014
TURKISH OPHTHALMOLOGY ASSOCIATION 48TH NATIONAL CONGRESS
5-9 NOVEMBER 2014
CERTIFICAE OF ATTENDANCE EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS
5-9 SEMPTEMBER 2015
TURKISH OPHTHALMOLOGY ASSOCIATION 40TH NATIONAL CONGRESS
01 NOVEMBER 2016
TURKISH OPHTHALMOLOGY ASSOCIATION 50TH NATIONAL CONGRESS
09-13 NOVEMBER 2016
40TH SPRING SYMPOSIUM PEDIATRIC OPHTHALMOLOGY
26-28 MAY 2017
TURKISH OPHTHALMOLOGY ASSOCIATION 52ND NATIONAL CONGRESS
NOVEMBER 2018
TURKISH OPHTHALMOLOGY ASSOCIATION 53RD NATIONAL CONGRESS
NOVEMBER 2019
TURKISH OPHTHALMOLOGY ASSOCIATION 54TH NATIONAL CONGRESS
NOVEMBER 2020
TURKISH OPHTHALMOLOGY ASSOCIATION 55TH NATIONAL CONGRESS
NOVEMBER 2021
TURKISH OPHTHALMOLOGY ASSOCIATION 56TH NATIONAL CONGRESS
NOVEMBER 2022
TURKISH OPHTHALMOLOGY ASSOCIATION 57TH NATIONAL CONGRESS
NOVEMBER 2023
EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS 2023
TURKISH OPHTHALMIC ASSOCIATION 58TH NATIONAL CONGRESS
NOVEMBER 2024
Mostrar másCV
Place and Date of Birth
Kırşehir, 1984
Foreign Languages
English
Education and Experience
Ankara University Faculty of Medicine, 2008
Hacettepe University Faculty of Medicine, 2015 (Specialization)
Mardin State Hospital 2015-2018
Kayseri City Hospital 2018-2022
SBÜ Gülhane Training and Research Hospital 2019-2020
Başakşehir Çam and Sakura City Hospital 2022-2024
Ludwig Maximilian University (Germany – Munich) 2022-2023
Case Experience
Active ophthalmologist for 9 years, over 5,000 case experience
Associations of which he is a member
Turkish Ophthalmology Association
Turkish Medical Association
Certificates
European Board of Ophthalmology (FEBO) (2018)
International Council of Ophthalmology, Basic Science(2018)
International Council of Ophthalmology, Optic and Refraction(2018)
International Council of Ophthalmology, Clinical Science (2019)
International Council of Ophthalmology, Advanced Clinical Exam (FICO)(2020)
Books
1. Esra Vural, A Hakan Durukan. Retinal Prostheses. Innovative Health. Academician Publishing House
2. Esra Vural. Riboflavin in Corneal Crosslinking. Corneal Crosslinking Treatment. Anadolu Bookstore
Mostrar más
Graduated (M.D. From)
Doctor of Medicine, Faculty of Medicine, Phramongkutklao College of Medicine
Ophthalmology Certificate, Phramongkutklao Hospital
Sub-board / Fellowship in Corneal and Refractive Surgery at Khonkaen University
Theppachai Thammikasakul is currently working as Ophthalmologist at Intrarat Hospital
Mostrar másEl Dr. Jesús Jiménez Román es un destacado oftalmólogo mexicano especializado en el manejo y tratamiento del glaucoma, una de las enfermedades oculares más graves que puede llevar a la ceguera irreversible si no se diagnostica y trata a tiempo. Con más de 30 años de experiencia, ha centrado su carrera en ofrecer soluciones avanzadas para enfermedades oculares, tanto mediante la práctica clínica como a través de la investigación y el desarrollo tecnológico en el campo de la oftalmología.
El Dr. Jiménez Román obtuvo su título de Médico Cirujano en la Universidad Nacional Autónoma de México (UNAM), una de las instituciones más prestigiosas del país. Posteriormente, se especializó en oftalmología, donde comenzó su enfoque hacia las enfermedades que afectan el nervio óptico, particularmente el glaucoma. Además de estar certificado por el Consejo Mexicano de Oftalmología, ha participado en múltiples cursos y actualizaciones internacionales para mantenerse a la vanguardia en los últimos avances en su especialidad.
Actualmente, es el director y fundador del Global Glaucoma Institute, un centro especializado en la prevención, diagnóstico y tratamiento de esta enfermedad, con sedes en Ciudad de México, Guadalajara y Monterrey. Bajo su liderazgo, esta clínica se ha convertido en un referente nacional en el tratamiento de glaucoma y otras enfermedades oculares como la retinopatía diabética y la degeneración macular.
El glaucoma es una enfermedad que afecta el nervio óptico, causando una pérdida progresiva de la visión que, en sus etapas más avanzadas, puede derivar en ceguera irreversible. A menudo, el glaucoma se desarrolla sin síntomas evidentes, lo que hace que el diagnóstico temprano sea crucial. El Dr. Jiménez ha sido un defensor incansable de la detección temprana a través de exámenes oftalmológicos preventivos, especialmente en pacientes con factores de riesgo, como aquellos mayores de 60 años o con antecedentes familiares de glaucoma.
Una de las principales técnicas que utiliza en su clínica para detectar el glaucoma de manera temprana es la tomografía óptica coherente (OCT), que permite detectar daños en las fibras nerviosas del ojo incluso antes de que aparezcan problemas de visión. Esto es complementado con exámenes de campo visual y mediciones de la presión intraocular, herramientas esenciales para el diagnóstico preciso de la enfermedad.
El Dr. Jiménez también ha implementado el uso de telemedicina en su práctica oftalmológica. Este enfoque ha permitido a su equipo de especialistas analizar estudios a distancia y proporcionar diagnósticos rápidos y precisos, mejorando el acceso a atención oftalmológica especializada para más pacientes, especialmente aquellos que viven en áreas remotas.
El Global Glaucoma Institute, dirigido por el Dr. Jiménez, no solo se enfoca en la atención de glaucoma, sino que también aborda otras enfermedades oculares comunes que pueden llevar a la ceguera, como la retinopatía diabética, la catarata y la degeneración macular. En la clínica, se brinda atención integral que incluye diagnósticos oportunos y tratamientos personalizados para cada paciente. Este enfoque ha sido clave para prevenir la pérdida de visión en cientos de personas.
El Dr. Jiménez y su equipo atienden diariamente entre 120 y 150 pacientes en las distintas sedes del Global Glaucoma Institute, ubicadas en Ciudad de México, Guadalajara y Monterrey. Su misión es ofrecer atención de la más alta calidad, utilizando tecnología de vanguardia y brindando un enfoque integral que incluye la nutrición y el manejo de condiciones metabólicas que afectan la salud visual, como la diabetes.
Además de su labor clínica, el Dr. Jiménez ha enfatizado la importancia de la educación y la concienciación sobre el glaucoma y otras enfermedades oculares. Según sus estimaciones, el 4% de la población en México tiene glaucoma, y lo preocupante es que el 75% de ese grupo no sabe que padece la enfermedad. Por esta razón, se ha enfocado en campañas de sensibilización para que más personas acudan a revisiones oftalmológicas regulares.
La tecnología ha sido una aliada clave en la práctica del Dr. Jiménez Román. A lo largo de su carrera, ha sido pionero en implementar técnicas de diagnóstico avanzado para la detección temprana de glaucoma y otras enfermedades del ojo. Utiliza métodos como la tomografía óptica de coherencia, el cálculo del lente intraocular y estudios de campo visual, entre otros, para obtener diagnósticos precisos. Estos avances han permitido al Dr. Jiménez detectar el glaucoma incluso 10 años antes de que aparezcan los primeros síntomas en el campo visual del paciente.
Además de su trabajo clínico, el Dr. Jiménez ha explorado el uso de telemedicina para consultas a distancia, lo que ha facilitado el acceso a la atención oftalmológica en pacientes que no pueden acudir físicamente a las clínicas. Esta innovación ha sido fundamental durante la pandemia, cuando las consultas presenciales se vieron limitadas.
Como parte de su compromiso con la salud visual, el Dr. Jiménez ha sido un activo defensor de la educación y la concienciación sobre las enfermedades oculares. A través del Global Glaucoma Institute, ha liderado iniciativas para educar a la población sobre la importancia de las revisiones oftalmológicas regulares y la detección temprana de enfermedades que, si no se tratan a tiempo, pueden llevar a la ceguera.
El Dr. Jiménez también ha sido un impulsor del concepto de check-up oftalmológico, un examen integral que permite evaluar la salud visual de manera general y detectar cualquier anomalía en etapas tempranas. Este enfoque preventivo ha demostrado ser altamente efectivo, especialmente en pacientes con retinopatía diabética, una condición común en personas con diabetes que, de no ser tratada, puede llevar a la pérdida total de la visión.
El Dr. Jesús Jiménez Román se ha consolidado como uno de los oftalmólogos más importantes de México, especialmente en el campo del glaucoma. Su enfoque multidisciplinario, que incluye la prevención, diagnóstico temprano, tratamiento quirúrgico y el uso de tecnologías avanzadas como la telemedicina, lo ha posicionado como un líder en su campo. Su trabajo a través del Global Glaucoma Institute ha permitido que miles de pacientes en México y otras regiones reciban atención de primer nivel, evitando así la ceguera irreversible y mejorando su calidad de vida.
Mostrar más
Doctor of Bright Eye Clinic, Kyobo Tower, Gangnam
Graduated from Yonsei University Graduate School of Medicine
Ophthalmology resident, Yonsei University Sinchon Severance Hospital
Full-time physician at Yonsei University Sinchon Severance Hospital
Research clinical assistant professor at Yonsei University Sinchon Severance Hospital
Doctor of Ophthalmology, Siloam Eye Hospital
Ophthalmology specialist doctor in Korea
SMILE LASIK, ICL certified
Full member of the Korean Society of Plastic and Ophthalmology (KSOPRS)
Full member of the Korean Society of Pediatric Ophthalmology (KAPOS)
Mostrar másDoctor of Bright Eye Eye Clinic
Gyeongsang National University Hospital Retina Clinical Instructor
Ophthalmologist_Retina specialist doctor
Ophthalmology specialist doctor in Korea
SMILE LASIK, ICL certified
Full member of the Korean Ophthalmological Society (KOS)
Full member of the Korean Society of Cataract and Refractive Surgery (KSCRS)
Full member of Yeongnam Retina Society (KRS)
Full member of the Korean Contact Lens Society (KCLS)
Full Member of the Korean Uveal Society
Full member of the Korean Society of Optometry
Mostrar másDoctor of Bright Eye Clinic, Kyobo Tower, Gangnam
Former Doctor of the Department of Public Health
Former Samsung Miracle Eye Clinic Gangnam Branch Doctor
Ophthalmology resident at Korea University Anam Hospital
Korea University Anam Hospital, Department of Ophthalmology, External Eye Department/Clinical Instructor of Cataracts
Ophthalmology specialist doctor in Korea
SMILE LASIK, ICL certified
Full member of the Korean Ophthalmological Society (KOS)
Full member of Korean External Eye Society (KCS)
Full member of the Korean Society of Cataract and Refractive Surgery (KSCRS)
Full member of the Korean Society of Optometry
Mostrar másEducation
2019 İSTANBUL MEDİPOL UNIVERSITY, ASSOC. PROF. DR. - OPHTHALMOLOGY
2004 ISTANBUL PROF. DR. N. REŞAT BELGER BEYOĞLU E.A.H, SPECIALIZATION IN MEDICINE - OPHTHALMOLOGY
1999 ISTANBUL UNIVERSITY, ISTANBUL MEDICAL FACULTY
1999 ISTANBUL UNIVERSITY, ISTANBUL MEDICAL FACULTY
Publications
A. International Peer-Reviewed Journals:
Title: Comparison of different formulas for intraocular lens power calculation using a new optical biometer.
Title: Change in choroidal thickness after intravitreal injection for treatment of neovascular age-related macular degeneration: Ranibizumab versus aflibercept.
Title: Effect of aflibercept on persistent macular edema secondary to central retinal vein occlusion.
Title: Epithelium-off corneal cross-linking in progressive keratoconus: 6-year outcomes.
Authors: Eliaçık Mustafa, Karaman Erdur Sevil, Baltepe Altıok İnci, Gülkılık İbrahim Gökhan, Anıl Aslan Cemile, Kaya Faruk
Authors: Karabela Yunus, Eliaçık Mustafa, Kaya Faruk
Authors: Koçak İbrahim, Koçak Funda, Teker Bahri, Aydın Ali, Kaya Faruk, Hakan Baybora
Authors: Koçak İbrahim, Aydın Ali, Kaya Faruk, Koç Hacı
Authors: Baybora Hakan, Kaya Faruk, Koçak İbrahim, Karabela Yunus
Authors: Koçak İbrahim, Karabela Yunus, Karaman Mehmet, Kaya Faruk
B. Book Chapters:
Title: Corneal Cross-linking in Keratoconus.
Title: Intraocular Lens Power Calculation in Eyes with Previous Myopic Refractive Surgery.
Experience
2022 - 2023
Private Medipol Mega Hospitals Complex
2010 - 2010
Bezmialem Foundation University Faculty of Medicine
2010 - 2010
Bezmialem Foundation University Faculty of Medicine, Department of Ophthalmology
2001 - 2011
Vakif Gureba Training and Research Hospital, Department of Ophthalmology
2001 - 2011
Vakif Gureba Training and Research Hospital
2000 - 2001
Edirne Regional Hospital
2000 - 2001
Edirne Regional Hospital
Education
2000 Selçuk University, Ophthalmology
2000 SELÇUK UNIVERSITY, OPHTHALMOLOGY
1994 SELÇUK UNIVERSITY, FACULTY OF MEDICINE
1994 Selçuk University, Faculty of Medicine
Mostrar másDoctor of Bright Eye Clinic, Kyobo Tower, Gangnam
Ophthalmology resident, Inje University Ilsan Paik Hospital
Ophthalmology specialist doctor in Korea
SMILE LASIK, ICL certified
Full member of the Korean Ophthalmological Society (KOS)
Full member of the Korean Society of Cataract and Refractive Surgery (KSCRS)
Full member of the American Cataract and Refractive Society (ASCRS)
Full member of the Korean Contact Lens Society (KCLS)
Full member of Korean External Eye Society (KCS)
Mostrar másDoctor of Bright Eye Clinic, Kyobo Tower, Gangnam
Ophthalmology resident at Korea University Anam Hospital
External eye/cataract clinical examination at Korea University Anam Hospital
Ophthalmology specialist doctor in Korea
SMILE LASIK, ICL certified
Full member of the Korean Ophthalmological Society (KOS)
Full member of the Korean Society of Cataract and Refractive Surgery (KSCRS)
Full member of the European Society of Cataract and Refractive Surgery (ESCRS)
Mostrar másCurrent doctor of Bright Eye Clinic, Kyobo Tower, Gangnam
Ophthalmology resident, Samsung Seoul Hospital, Sungkyunkwan University
Ophthalmology specialist doctor in Korea
ICL/SMILE certification
Full member of the Korean Ophthalmological Society (KOS)
Full member of the Korean Society of Cataract and Refractive Surgery (KSCRS)
Full member of the Korean Contact Lens Society (KCLS)
Full member of the American External Eye Society (KCS)
Full member of the American Association for Research in Vision Function (ARVO)
Mostrar másCurrent Doctor of Bright Eye Clinic, Kyobo Tower, Gangnam
Former Bright Eye Clinic Jamsil Lotte Tower Doctor
Ophthalmology specialist doctor in Korea
SMILE LASIK, ICL certified
12 years of SMILE surgery experience (starting in 2012), more than 20,000 surgeries performed
ICL Ophtec Expert Surgeon Certification
Full member of the Korean Society of Cataract and Refractive Surgery (KSCRS)
Full member of the American Society of Cataract and Refractive Surgery (ASCRS)
Full member of the European Society of Cataract and Refractive Surgery (ESCRS)
Full member of the Korean Ophthalmological Society (KOS)
Full member of Korean External Eye Society (KCS)
Full member of the Korean Contact Lens Society (KCLS)
Full member of the Korean Society of Plastic and Ophthalmology (KSOPRS)
Mostrar másEl Dr. X se graduó de la Facultad de Medicina de la Universidad de Ankara, Turquía y de la Academia Médica Militar de Gülhane, Turquía. Es miembro de la Asociación Oftalmológica Turca y de la Asociación Médica Turca.
Mostrar másEl médico se graduó de la Escuela de Medicina de la Universidad de Estambul y ha completado becas en Clínicas Oftalmológicas Universitarias en Colonia y Tubinga, Alemania. Son miembros de DOG, AAO, ASCRS y ESCRS, y cuentan con certificaciones en aplicación de LASIK, corrección de presbicia con lentes intraoculares multifocales, técnicas de fijación escleral, cross-linking de colágeno corneal, aplicaciones de femtosegundos para cirugía del segmento anterior y análisis de topografía corneal. Han completado un doctorado en terapia inmunomoduladora de la uveítis y han asistido a varias conferencias y reuniones, incluida la 42ª reunión anual de la Sociedad Europea de Oftalmología Pediátrica, el Congreso Mundial de Oftalmología y el Congreso de la Sociedad Europea de Cataratas y Cirujanos Refractivos.
Mostrar másEducation :
Istanbul University, Istanbul Faculty of Medicine September 2004 – July 2010
Istanbul University, Istanbul Faculty of Medicine, Department of Orthopaedics, Residency February 2011 - April 2011
Istanbul University, Istanbul Faculty of Medicine, Department of Ophthalmology, Residency August 2011 - March 2016
Thomas Jefferson University, Wills Eye Institute, Ocular Oncology Department, Observership August 2012 - September 2012
Turkish Health Ministry, Hakkari State Hospital, Ophthalmology Clinic, Eye M.D July 2016 – March 2018
Van Yuzuncu Yil University, Faculty of Medicine, Ophthalmology Department, Assistant Professor, March 2018 – October 2021
Van Yuzuncu Yil University, Faculty of Medicine, Ophthalmology Department, Associate Professor, October 2021 – December 2021
Istanbul Yeni Yuzyil University, Faculty of Medicine, Ophthalmology Department, Associate Professor, January 2022 – present
Educational Qualifications :
1. International Council of Ophthalmology (ICO) Basic Sciences assessment in ophthalmology examination passed on April 2017
2. International Council of Ophthalmology (ICO) Optics & Refraction examination passed on April 2017
3. International Council of Ophthalmology (ICO) Clinical Sciences in Ophthalmology examination passed on April 2018
4. Awarded for ICO-STAAR Surgical Three-Month Fellowship in Vitreo-Retina at the University of Kansas, Medical School, Dept. of Ophthalmology in Prairie Village, KS, USA under the supervision of Prof. Radwan Aijlan from April 6, 2020, to July 5, 2020.
5. International Council of Ophthalmology (ICO) Advanced Examination in Ophthalmology examination passed on July 2020.
6. United States Medical Licensing Examination (USMLE) Step 1 passed on January 7 2021 with 221 pts.
7. United States Medical Licensing Examination (USMLE) Step 2 CK passed on August 25 2021 with 214 pts.
Presentations & Posters :
1. 47th National Ophthalmology Congress, The effectiveness of photodynamic therapy on circumscribed choroidal hemangioma, Oral presentation, Ozer MD, Tuncer S, November 2013, Antalya, Turkey.
2. 48th National Ophthalmology Congress, Clinical features and treatment outcomes of primary ophthalmic rhabdomyosarcoma: Tertiary center experience, Ozer MD, Ulas MG, Tuncer S, Oral presentation, November 2014, Antalya, Turkey
3. 2015 ISOO Meeting, Long-term Outcome of Combined (Perilesional Injection and Topical) Interferon Alpha-2b Therapy in the Management of Ocular Surface Squamous Neoplasia, Tuncer S, Ozer MD, Oral presentation, June 2015, Paris, France
4. 49th National Ophthalmology Congress. Clinical presentation patterns of pediatric Vogt-Koyanagi-Harada syndrome and long-term follow-up results, Kiragi D, Ozer MD, Lider-Gezer M, Oray M, Tugal-Tutkun I, Oral presentation, November 2015, Istanbul, Turkey.
5. 49th National Ophthalmology Congress, Central corneal thickness and optic disc dimensions in glaucoma patients, Bayraktar S, Ozer MD, Izgi B, Poster, November 2015, Istanbul, Turkey.
6. 49th National Ophthalmology Congress, Analysis of retinal nerve fiber layer and choroidal thickness in patients with systemic sclerosis to identify a potential risk factor for normal-tension glaucoma, Ceylan E, Ozer MD, Ekinci M, Yilmaz YC, Poster, November 2015, Istanbul, Turkey.
7. 50th National Ophthalmology Congress, Treatment of age-related macular degeneration with intravitreal Ranibizumab: Real-life experience, Cebeci Z, Yilmaz YC, Ozer D, Kir N, Oral presentation, November 2016, Antalya, Turkey
8. 51st National Ophthalmology Congress, A rarely seen complication of cataract surgery: Endocapsular Hematoma, Ozer MD, Batur M, Artuç T, Seven E, Tekin S, Poster, November 2017, Antalya, Turkey
9. 52nd National Ophthalmology Congress, Nanophthalmos Wıth Macular Folds, Yavuzer B, Batur M, Seven E, Ozer MD, Poster, November 2018, Antalya, Turkey
10. 52nd National Ophthalmology Congress, Clinical Features and Treatment Methods of Orbital Cellulite Cases, Mesen S, Tekin S, Batur M, Duzenli U, Seven E, Ozer MD, Poster, November 2018, Antalya, Turkey
11. 52nd National Ophthalmology Congress, Case Series: Ocular Chemical Burns, Tekin S, Artuç T, Batur M, Ozer MD, Poster, November 2018, Antalya, Turkey
12. 52nd National Ophthalmology Congress, Sensory-Neural Hearing Loss affecting Low frequencies in Patients with Pseudoexfoliation, Ozer MD, Batur M, Duzenli U, Seven E, Tekin S, Poster, November 2018, Antalya, Turkey
13. 52nd National Ophthalmology Congress, Silicone tube intubation by Ritleng stent in children over two years of age with nasolacrimal duct obstruction, Ocal H, Seven E, Tekin S, Ozer MD, Batur M, Poster, November 2018, Antalya, Turkey
14. 52nd National Ophthalmology Congress, Cherry Red Spot Appearance in Macula and Alkaptonuria: A Case Report, Mesen S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turkey
15. 52nd National Ophthalmology Congress, A Rare Complication in Intravitreal Dexamethasone Implantation: Implant Migration to the Anterior Chamber, Gulbay S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turkey
16. 52nd National Ophthalmology Congress, Effect of Coenzyme Q10 Eye Drop on Corneal Wound Healing in Bacterial Keratitis Treatment, Batur M, Seven E, Tekin S, Ozer MD, Oral presentation, November 2018, Antalya, Turkey
17. 19th Euretina Congress, Effect of reduced production of aqueous humor on bacterial growth potential in rabbit eyes, Batur M, Ozer M, Tekin S, Oral presentation, September 2019, Paris, France
18. 53rd National Ophthalmology Congress, Evaluation of the clinical features of patients with hyphema due to blunt trauma, Seven E, Kebapci F, Tekin S, Batur M, Ozer MD, Oral presentation, November 2019, Antalya, Turkey
19. 53rd National Ophthalmology Congress, Adherence to drop therapy and the relationship of compliance with progression in glaucoma patients, Tekin S, Ocal H, Seven E, Batur M, Ozer MD, Poster, November 2019, Antalya, Turkey
20. 53rd National Ophthalmology Congress, Bilateral sudden-transient vision loss after central venous catheter removal, Altas AS, Batur M, Sayir F, Seven E, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turkey
21. 53rd National Ophthalmology Congress, Clinical Evaluation of Argon Laser Photocoagulation Therapy in Patients with Retinal Tears, Ocal H, Seven E, Batur M, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turkey
22. 53rd National Ophthalmology Congress, Macular damage due to laser epilation: a case report, Batur M, Ocal H, Ozer MD, Seven E, Tekin S, Poster, November 2019, Antalya, Turkey
23. 53rd National Ophthalmology Congress, Phototoxic Maculopathy Due to Extreme Usage of Infrared Illuminator Assembled Night Vision Handheld Scope, Ozer MD, Batur M, Seven E, Tekin S, Savasan M, Poster, November 2019, Antalya, Turkey
24. 54th National Ophthalmology Congress, Internal Ophthalmolplegia after Chickenpox Infection, Gedik AC, Ozer MD, Poster, November 2020, Virtual, Turkey.
Work Experience :
1. Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis (SARILNIUSATURN-Sanofi), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)
2. Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD-A&C-Servier), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)
3. A Randomized, Double-masked, Placebo-controlled Study of the Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD-B-Servier), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)
4. A 12-month, randomized, double-masked, sham-controlled, multicenter study to evaluate the efficacy and safety of 0.5 mg ranibizumab intravitreal injections due to vascular endothelial growth factor (VEGF) driven macular edema (RFB002-Novartis), Injection sub-investigator (Principle investigator: Prof. Dr. Nur Kir)
5. A Phase III multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of Lampalizumab administered intravitreally to patients with geographic atrophy secondary to age-related macular degeneration (GX29176-Roche), Photographer (Principle investigator: Prof. Dr. Nur Kir)
Selected as an active member of the Turkish Ophthalmological Association, Young Ophthalmologist Council, 2020 - present
Mostrar más